Top

Published in:

01-02-2006 | Commentary

The Molecular Adsorbent Recirculating System (MARS^®) in the intensive care unit: a rescue therapy for patients with hepatic failure

Author: Faouzi Saliba

Published in: Critical Care | Issue 1/2006

Abstract

Treatment in the intensive care unit of patients with end-stage liver disease has been limited. Liver transplantation has been a major improvement in this and has become standard in the management of these patients. However, many patients die awaiting liver transplantation, mainly due to the scarcity of organ donors. Conventional hemodialysis techniques have little or no effect on liver detoxification and do not improve the prognosis of these patients. In patients with acute hepatic failure, the majority of endogenous toxins leading to organ failure and accumulating in the blood are bound to albumin; therefore, the concept of albumin dialysis is of major interest. To date, the most widely developed system has been the Molecular Adsorbent Recirculating System (MARS^®), which is based on the selective removal of albumin-bound toxins from the blood. MARS^® enables simultaneous liver and kidney detoxification, improving the patient's clinical condition. It is a major improvement in the management of patients with hepatic failure that could permit, when appropriately indicated, recovery from an acute episode and enhance the chances of survival while waiting for an available organ donor.

O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1998, 94: 1186-1192.

Wilkinson AH, Ash SR, Nissenson AR: Hemodiabsorption in treatment of hepatic failure. J Transpl Coord 1998, 8: 43-50.CrossRefPubMed

Iwai H, Nagaki M, Naito T, Ishiki Y, Murakami N, Sugihara J, Muto Y, Moriwaki H: Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998, 26: 873-876. 10.1097/00003246-199805000-00021CrossRefPubMed

Wang YJ, Wang ZW, Luo BW, Liu HL, Wen HW: Assessment of resin perfusion in hepatic failure in vitro and in vivo. World J Gastroenterol 2004, 10: 837-840.PubMed

Rifai K, Er T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D: Prometheus a new extracorporeal system for the treatment of liver failure. J Hepatol 2003, 39: 984-990. 10.1016/S0168-8278(03)00468-9CrossRefPubMed

Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, Hwang YJ, Pascher A, Gerlach JC, Neuhaus P: In vitro comparison of the Molecular Adsorbent Recirculation System (MARS) and Single-pass Albumin Dialysis (SPAD^®). Hepatology 2004, 39: 1408-1414. 10.1002/hep.20195CrossRefPubMed

Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Nôldge-Schomburg G: Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001, 12: S75-S82. 10.1159/000047685PubMed

Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, Nudo F, Bussotti A, Corradini S, Martelli S, Berloco PB: One hundred sixteen cases of acute liver failure treated with Mars. Transplant Proc 2005, 37: 2557-2559. 10.1016/j.transproceed.2005.07.015CrossRefPubMed

Saliba F, Ichaï P, Gonzales M, Azoulay D, Adam R, Castaing D, Samuel D: Extracorporeal liver support using the MARS^®Albumin dialysis system: a rescue therapy in patients with end-stage liver disease and renal failure. Liver Transpl 2005, 11: Abs 41. C-11

10.

Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, et al.: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000, 6: 277-286. 10.1053/lv.2000.6355CrossRefPubMed

11.

Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, et al.: Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002, 36: 949-958.CrossRefPubMed

12.

Hassanein T, Tofteng F, Brown R, McGuire B, Lynch P, Mehta R, Larsen F, Gornbein J, Stange J, Blei A: Efficacy of albumin dialysis (MARS) in patients with cirrhosis and advanced grades of hepatic encephlopathy: a prospective, controlled, randomized multicenter trial. Hepatology 2004,38(LB04):726A.

13.

Campli C, Gaspari R, Mignani V, Stifano G, Santoliquido A, Verme LZ, Proietti R, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A: Successful Mars treatment in severe cholestatic patients with acute on chronic liver failure. Artif Organs 2003, 27: 565-569. 10.1046/j.1525-1594.2003.07138.xCrossRefPubMed

14.

Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R: Extra-corporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003, 38: 24-31. 10.1016/S0168-8278(02)00334-3CrossRefPubMed

15.

Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R: First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 2004, 50: 332-337.PubMed

16.

Kellersmann R, Gassel H-J, Buehler C, Thiede A, Timmermann W: Application of Molecular Adsorbent Recirculating System in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. Liver 2002,22(Suppl 2):56-58.CrossRefPubMed

17.

Ben Abraham R, Szold O, Merhav H, Biderman P, Kidron A, Nakache R, Oren R, Sorkine P: Rapid resolution of brain oedema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc 2001, 33: 2897-2899. 10.1016/S0041-1345(01)02241-2CrossRefPubMed

18.

Schmidt LE, Wang LP, Hansen BAH, Larsen FS: Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transplant 2003, 9: 290-297. 10.1053/jlts.2003.50051CrossRef

19.

Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care 2006, 10: R24. 10.1186/cc3985PubMedCentralCrossRefPubMed

Title: The Molecular Adsorbent Recirculating System (MARS®) in the intensive care unit: a rescue therapy for patients with hepatic failure
Author: Faouzi Saliba
Publication date: 01-02-2006
Publisher: BioMed Central
Published in: Critical Care / Issue 1/2006
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc4825

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Molecular Adsorbent Recirculating System (MARS^®) in the intensive care unit: a rescue therapy for patients with hepatic failure

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2006

Erythromycin for prokinesis: imprudent prescribing?

Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis

Alvarez A (Editor-in-Chief), Brodsky J, Alpert M, Cowan G (Associated Editors): Morbid Obesity: Peri-operative Management. New York: Cambridge University Press

Ropper AH, Gress DR, Diringer MN, Green DM, Mayer SA, Bleck TP: Neurological and Neurosurgical Intensive Care, 4th ed. Philadelphia: Lippincott Williams & Wilkins

Imposed work of breathing during high-frequency oscillatory ventilation: a bench study

Bench-to-bedside review: Weaning failure – should we rest the respiratory muscles with controlled mechanical ventilation?